GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
pharmaceutical manufacturers in Europe:
sales of 48.29 billion Swiss Francs [US$51.05 billion]
of which 78%
was Innovative Medicines),
(37.63 billion Euros [US$42.33 billion]
of which 68%
was Pharmaceuticals), and
based in GERMANY
(43.55 billion Euros [US$48.98 billion]
of which 46%
During the year ended December of 2019, sales at
GlaxoSmithKline plc were £33.75 billion (US$42.09 billion).
increase of 9.5%
versus 2018, when the company's sales were £30.82 billion.
This was the fifth consecutive year of sales increases at GlaxoSmithKline plc
(and since 2014, sales have increased a total of 47%).
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
21.4% in 2019, from
£5.89 billion to £7.16 billion.
GlaxoSmithKline plc also saw significant increases in sales in
Consumer Healthcare (up 17.5% to £9.00 billion)